HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2018-12-26 for HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM manufactured by Accriva Diagnostics.

Event Text Entries

[131942244] (b)(4). Method: analysis of production records. No ncs or capas related to the instrument. Main pcb replaced in july 2015 for an unrelated complaint. Results: no findings available. Conclusion: conclusion not yet available. Accriva diagnostics has requested all data required for form 3500a. This is the initial 30-day report that precedes the instrument evaluation. Mdr 2250033-2018-00029 follow-up #1 will be submitted after the device is returned to the manufacturer and the evaluation is completed.
Patient Sequence No: 1, Text Type: N, H10


[131942245] Healthcare professional reported that a hemochron signature elite and low-range act system reported inconsistent patient results. The patient suffered an acute coronary event, was successfully resuscitated and was started on intravenous heparin during an emergency pci and stent placement. The target act was >200 seconds. The first 2 blood samples generated outside reportable range (oor) high errors, the second of which was considered suspicious. A second dose of intravenous heparin was given and the act result was reported as 164 seconds, which lower than expected. A back-up hemochron signature elite was utilized for the remainder of the procedure using the same lot of low-range act cuvettes. Two blood samples were subsequently drawn for act measurements and both reported values were >200 seconds as was expected. Electronic and liquid qc passed prior to the procedure. No bleeding or other medical complications were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2250033-2018-00029
MDR Report Key8198241
Report SourceHEALTH PROFESSIONAL
Date Received2018-12-26
Date of Report2019-01-14
Date of Event2018-12-04
Date Mfgr Received2019-01-14
Device Manufacturer Date2011-06-01
Date Added to Maude2018-12-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8582632490
Manufacturer G1ACCRIVA DIAGNOSTICS
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal Code92121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM
Generic NameSYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
Product CodeJPA
Date Received2018-12-26
Returned To Mfg2018-12-20
Model NumberELITE
Catalog NumberELITE
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerACCRIVA DIAGNOSTICS
Manufacturer Address6260 SEQUENCE DRIVE SAN DIEGO CA 92121 US 92121


Patients

Patient NumberTreatmentOutcomeDate
10 2018-12-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.